-
Posted by
Two Blokes Jul 22 -
Filed in
Stock
-
8 views
Sarepta Therapeutics said on Monday that it will pause all shipments of its Elevidys gene therapy in the United States after a muscular dystrophy patient who received a different, experimental treatment died.
